One set of operators, tested domain by domain.
The operators are defined independently of any domain. The research programme tests this in 24 domains, each with a first measurable test and its safeguards. The method is the same everywhere.
Purpose
RSOS grew from one seed: healing, transforming, signalling and evolving. It integrates the whole of human experience, including its shadow, so that what is integrated can be transformed rather than denied. Because its seed is healing, RSOS is used with consent and for the good of the person or system it works with, never to harm or coerce.
How the design carries it
- Operations on people need their consent, checked by the compiler (E018).
- Standing consent is valid only inside a declared network with members and laws (E021).
- The Spine blocks predicted harm (E019).
- The White Dragon admits only changes that are measurable, new and of good intention.
- The author does not support using RSOS to deceive, manipulate, surveil or harm people, or to act on anyone without consent. Responsible use
Method in every domain
1 · Bind the host
Its parts, channels, states and measures.
2 · Pre-register
Predictions are fixed and committed before any data.
3 · Strongest baseline
Run against the best available alternative, not a weak one.
4 · Report every failure
Next to the successes, with code and data where permitted.
5 · Replicate
An independent team repeats it before any strong claim.
The 24 domains
Status today: AI agent systems have real-host results (A1–A5). Every other domain is specified with its first test and has not been run yet.
| Domain | First measurable test | Safeguards |
|---|---|---|
| AI agent systems | A1–A5 done; A5b (thinking control), A7 (classical baselines, adversarial faults) and a cross-model run next | Standard |
| Computational psychiatry | Retrospective modelling of published case formulations; agreement against clinicians | Clinician partner, ethics approval; research tool, not treatment |
| Clinical psychology and psychotherapy | Feasibility study with therapists on formulation quality | As above; not a medical device |
| Neuroscience | Multi-channel anchors vs name-only cues (V1 prediction) | Ethics approval; healthy volunteers first |
| Memory and cognitive training | Recall and transfer vs a method-of-loci control | Healthy volunteers |
| States and performance | Within-person anchored vs unanchored task blocks | No clinical claims |
| Decision-making and leadership | Two-week pre-registered pilot on decision quality | Consent |
| Sport | Pre-registered performance pilot with a coach | Athlete consent |
| Negotiation and diplomacy | Simulated negotiation outcomes vs standard preparation | — |
| Education and learning | Classroom pilot: transfer to novel problems | Guardian consent for minors |
| Human and organisational development | Longitudinal tracking against self-report | Consent |
| Finance | Reconciliation benchmark vs standard tools | Not investment advice |
| Economics | Reproduce a published agent-based model; compare policy predictions | — |
| Computational forensics | Benchmark on public, anonymised datasets | Legal review; never applied to individuals without due process |
| Cybersecurity (defensive) | Tamper-detection benchmark | Defensive use only |
| Socio-technical safety | Model a public incident; test the redesign | — |
| Cybernetics and control | Control benchmark with drifting plants | — |
| Engineering design and innovation | A2 on a physical or software design task | — |
| Healthcare operations | Simulated handover drift study | Clinical governance |
| Law and compliance | Compile a public regulation; test violation detection | Legal review |
| Scientific discovery and R&D | Does the engine propose known breakthroughs from their precursors? | — |
| Human–AI interfaces and accessibility | HT2 after a learning phase; later with AAC users | Accessibility experts; consent |
| Supply chains and logistics | Simulated multi-party inventory drift | — |
| Planetary and urban systems | Reproduce a published urban or climate-economy model | — |
No clinical, forensic or financial claim is made before validated trials in that domain. Full programme: RESEARCH_PROGRAMME.md.